🇺🇸 FDA
Patent

US 8178555

Apoptosis signal-regulating kinase 1 inhibitors

granted A61KA61K31/437A61K31/496

Quick answer

US patent 8178555 (Apoptosis signal-regulating kinase 1 inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K31/437, A61K31/496, A61K31/506, A61K31/519